INTERNATIONAL PATENT: DIAMEDICA THERAPEUTICS, INC. FILES APPLICATION FOR "INTRAVENOUS COMPOSITIONS OF TISSUE KALLIKREIN-1 AND RELATED METHODS"

GENEVA, Oct. 28 -- DIAMEDICA THERAPEUTICS, INC. (301 Carlson Parkway, Suite 210Minneapolis, Minnesota 55305) filed a patent application (PCT/US2025/024594) for "INTRAVENOUS COMPOSITIONS OF TISSUE KALLIKREIN-1 AND RELATED METHODS" on Apr 14, 2025. With publication no. WO/2025/221694, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHAH, Ambarish (c/o DiaMedica Therapeutics, Inc.301 Carlson Parkway, Suite 210Minneapolis, Minnesota 55305), PAULSON, Nick (c/o DiaMedica Therapeutics, Inc.301 Carlson Parkway, Suite 210Minneapol...